Home Your basket
• Does indermil glue improv...
   Price 5.50 €
• The ultra-low resistance ...
   Price 5.50 €
• Cervico facial lymphangio...
   Price 10.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Modified butterfly cartil...
   Price 10.50 €
• Supra and infra hyoid mid...
   Price 10.50 €
• Adaptation and validation...
   Price 10.50 €
• The input of autogenous g...
   Price 10.50 €
• Recurrent mandibular amel...
   Price 12.50 €
• Kikuchi-Fujimoto’s diseas...
   Price 10.50 €
• Training strategies of th...
   Price 8.50 €
• Validation of a clinical ...
   Price 10.50 €
• Phonatory threshold press...
   Price 10.50 €
• Salivary gland choristoma...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Total pharyngolayngectomy...
   Price 10.50 €
• Thyroid tuberculosis asso...
   Price 5.50 €
• Endoscopic medialization ...
   Price 8.50 €
• Recurrences of pleomorphi...
   Price 10.50 €
• Parapharyngeal tumours: M...
   Price 10.50 €
• Paraganglioma of the cere...
   Price 5.50 €
• Laryngeal paraganglioma m...
   Price 8.50 €
• Early PTH assay after tot...
   Price 10.50 €
• Merkel cell carcinoma of ...
   Price 8.50 €
• Unilateral laryngeal para...
   Price 10.50 €
• Sinonasal malignant schwa...
   Price 5.50 €
• Ethmoidal metastasis reve...
   Price 8.50 €
• Inferior turbinate hypert...
   Price 10.50 €
• Rhinophyma in a black afr...
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Allergic and pneumologic ...
   Price 8.50 €
• An original case of laryn...
   Price 8.50 €
• Aspects of voice quality ...
   Price 5.50 €
• A giant lipoma of parapha...
   Price 8.50 €
• Giant form of infantile m...
   Price 8.50 €
• Autologous bone pate in m...
   Price 10.50 €
• Voice-breaking in adolesc...
   Price 10.50 €
• Art and nose....
   Price 8.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €

Total Order 337.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2013 o

CANCER

Two cases of primary malignant melanoma of the larynx: A rare pathology


Authors : Chaput B, De Bonnecaze G, Vergez S, Garrido I, Grolleau JL, Benlyazid A. (Toulouse)

Ref. : Rev Laryngol Otol Rhinol. 2013;134,2:105-108.

Article published in french
Downloadable PDF document french



Summary : Introduction: Primary malignant melanoma of the larynx is a very rare entity. There are less than sixty cases described in the literature. Through both cases, we describe and discuss the clinical management of melanoma of the larynx. Clinical cases: Two men aged 80 and 61 years were supported for MPL. The tumor was revealed by persistent dysphonia for the first. For the second, it was a second melanoma of laryngeal location. In both cases it was performed a total laryngectomy extended to the first tracheal rings with bilateral lymphadenectomy asso­ciated with adjuvant radiotherapy. Discussion: Excision margins with oncological safety are necessary to except a curative surgery. Still controversial, the adjuvant radiotherapy seems to provide a benefit in terms of local control. The place of targeted therapies remains unclear. However, no prognostic factor is currently clearly identified for this disease. Conclu­sion: Rare tumor, the MPL is associated with a very poor prognosis. Resective surgery followed by adjuvant radio­therapy is for us the treatment of choice.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE